Association Analysis of Interleukin-17 Gene Polymorphisms with the Risk Susceptibility to Tuberculosis
Overview
Affiliations
Background: Recently, many institutions have investigated the associations of interleukin-17 (IL17) polymorphisms with tuberculosis (TB) susceptibility, while those results are inconsistent. The purpose of this meta-analysis is to comprehensively assess whether IL17A rs22275913, IL17F rs763780, and IL17A rs3748067 polymorphisms are correlated with TB risk.
Methods: Electronic bibliographic databases were searched for case-control studies which potentially focused on the relationship between the aforementioned polymorphisms and TB risk on October 15th, 2015. Pooled odds ratios (OR) combined with 95 % confidence intervals (CI) were employed to assess the associations.
Results: There was no significant association of IL-17A rs22275913 polymorphism with susceptibility to TB in Asians or Caucasians. For IL-17A rs3748067 polymorphism, significant associations were observed in Asian (T vs. C: OR 1.461, 95 % CI 1.158-1.844, P = 0.001; TT vs. CC: OR 1.871, 95 % CI 1.140-3.069, P = 0.013; TT/TC vs. CC: OR 1.392 95 % CI 1.062-1.825, P = 0.017; TT vs.
Tc/cc: OR 1.820, 95 % CI 1.111-2.981, P = 0.017). For IL-17F rs763780, we detected the significant associations under allele contrast, heterozygote, dominant and recessive models (C vs. T: OR 1.571, 95 % CI 1.352-1.824, P = 0.000; CT vs. TT: OR 1.624, 95 % CI 1.346-1.958, P = 0.000; CT/TT vs. TT: OR 1.639, 95 % CI 1.381-1.946, P = 0.000, respectively). The corresponding results were also detected in Asian populations (C vs. T: OR 1.068, 95 % CI 1.380-1.875, P = 0.000; CT vs. TT: OR 1.689, 95 % CI 1.390-2.053, P = 0.000; CT/TT vs. TT: OR 1.695, 95 % CI 1.420-2.023, P = 0.000), while there were no significant associations in Caucasian.
Conclusion: IL-17F rs763780 allele C and IL-17A rs3748067 allele C may be involved in the susceptibility to TB in Asian populations. There were no significant associations between IL-17A rs22275913 polymorphism and risk of TB.
Elmadbouly A, Abdul-Mohymen A, Eltrawy H, Elhasan H, Althoqapy A, Amin D J Genet Eng Biotechnol. 2023; 21(1):90.
PMID: 37665411 PMC: 10477154. DOI: 10.1186/s43141-023-00542-5.
Islam M, Aziz M, Shahriar M, Islam M Cancer Control. 2022; 29:10732748221143879.
PMID: 36458977 PMC: 9720807. DOI: 10.1177/10732748221143879.
Associations between polymorphisms in genes of base excision repair pathway and lung cancer risk.
Liu S, Xiao Y, Hu C, Li M Transl Cancer Res. 2022; 9(4):2780-2800.
PMID: 35117636 PMC: 8799111. DOI: 10.21037/tcr.2020.02.44.
Lung Neutrophilic Recruitment and IL-8/IL-17A Tissue Expression in COVID-19.
Azevedo M, Zanchettin A, De Paula C, da Silva Motta Junior J, Malaquias M, Raboni S Front Immunol. 2021; 12:656350.
PMID: 33868301 PMC: 8044579. DOI: 10.3389/fimmu.2021.656350.
Protective efficacy of an attenuated Mtb ΔLprG vaccine in mice.
Martinot A, Blass E, Yu J, Aid M, Mahrokhian S, Cohen S PLoS Pathog. 2020; 16(12):e1009096.
PMID: 33315936 PMC: 7769599. DOI: 10.1371/journal.ppat.1009096.